π§ͺ λ―Έμλ¬Όνλ μνλ²κ³Ό μ ν©μ± μν
- λ΄μ© μμ½:
λ―Έμλ¬Όνλ μνμ λ¬΄κ· μ μ κ° μλ μΌλ° μμ μμ½ν, μλ£, μ€κ°μ ν λ±μ λμμΌλ‘ λ―Έμλ¬Ό μ€μΌ μμ€μ νμΈνλ νμ μνμ λλ€.
μνλ² μ ν©μ± μνμ μ μ μ±λΆμ΄ λ―Έμλ¬Ό κ²μΆμ λ°©ν΄λ₯Ό μ£Όλμ§ μ¬λΆλ₯Ό κ²μ¦νλ λ¨κ³λ‘, μ νν λ―Έμλ¬Ό μ μΈ‘μ μ΄ κ°λ₯ν΄μΌ ν©λλ€.
β λ―Έμλ¬Όνλ μν μ£Όμ νλͺ©- μ΄ νΈκΈ°μ± λ―Έμλ¬Όμ(TAMC): μ΄μμλ μΈκ· μ μΈ‘μ
- μ΄ μ§κ· μ(TYMC): κ³°ν‘μ΄ λ° ν¨λͺ¨ μ μΈ‘μ
- νΉμ λ―Έμλ¬Ό μν: E. coli, S. aureus, P. aeruginosa λ± μ ν΄κ· κ²μΆ
β μνλ² μ ν©μ± μν μ‘°μ°¨ νμλ
1. νμ€ κ· μ£Ό μ€λΉ (ATCC κ· μ£Ό μ¬μ©)
↓
2. μ ν λλ μλ£ μ€λΉ (ν¬μλ°°μ μ€μ )
↓
3. νμ€ κ· μ£Ό λλ κ³λλ°°μ ν μ μ’
(100 CFU μ λ), κ³λμλ μ΅λ 5κ³λκΉμ§ νμ©
↓
4. λ°°μ (μ μ ν λ°°μ§ λ° μ‘°κ±΄ νμ)
↓
5. λ―Έμλ¬Ό νμμ¨ νκ° (νμ©κΈ°μ€ 50~200%)
↓
6. νμμ¨ λΆμ‘±μ μνλ² μμ λ° μ¬νκ°
μ μ λ³ μν 쑰건 μμ½
μ μ μ’
λ₯μν λ°©λ²λΉκ³
| μ μ , μΊ‘μμ | μ§μ λ°°μ λλ ν¬μ ν λ°°μ | λΆμ©μ± μ±λΆ μμ κ²½μ° μ μ ν ν¬μ |
| μ°κ³ μ , ν¬λ¦Όμ | νλ©΄νμ±μ (Polysorbate 80 λ±) μ¬μ© ν¬μ | μ μ± μν ν μν |
| μ‘μ , μ£Όμ¬μ | μ§μ ν¬μ λλ λ©Έκ· ν¬μμ‘ μ¬μ© | μ리μ 쑰건μ λ§μΆ° ν¬μ νμ |
| 건쑰λΆλ§μ , μλ£μ½ | λ©Έκ· μ λλ μ ν©ν ν¬μμ μ¬μ© | μμ μ©ν΄ νμΈ ν μ§ν |
β μ£Όμ κ°μ΄λλΌμΈ λ°μ·
π USP <61> / <62>
- "If inhibitory effects of the product are noted, a suitable neutralization method must be employed to allow microbial recovery."
- "Recovery of test microorganisms should not be less than 70% compared to the control test."
π EP 2.6.12 / 2.6.13
- "Test method validation must demonstrate that the presence of the product does not adversely affect the recovery of microorganisms."
- "Neutralizers or diluents may be used to minimize antimicrobial properties."
π JP 4.05 / 4.06
- "The validation shall confirm that the growth promoting and inhibitory properties of the medium are suitable for the microorganisms tested."